FORMULATION, OPTIMIZATION, AND CHARACTERIZATION OF BIOCOMPATIBLE INHALABLE D-CYCLOSERINE-LOADED ALGINATE-CHITOSAN NANOPARTICLES FOR PULMONARY DRUG DELIVERY
DOI:
https://doi.org/10.22159/ajpcr.2016.v9s2.11814Abstract
ABSTRACT
Objective: To prepare Nanoparticulate dosage form having improved drug bioavailability and reduced dosing frequency of antitubercular drugs
which will helps in improving patient compliance in the treatment of multi-drug resistant tuberculosis (MDR-TB).
Methods: Ionotropic gelation method was used to prepare D-cycloserine (D-CS)-loaded alginate-chitosan nanoparticles, and the particles are
characterized by their particle size and morphology using particle size analyzer and scanning electron microscopy (SEM). X-ray diffraction (XRD),
differential scanning calorimetry (DSC), and Fourier-transformed infrared (FTIR) studies were used to determine drug-polymer interactions and drug
entrapment. Entrapment efficiency, drug loading (DL), particle size, and zeta potential of nanoparticles were also studied. The 2
factorial designs of
experiments by Design-Expert
®
V9 were used to optimize the particle size and entrapment efficiency of nanoparticles.
Results: The optimized batch had shown the entrapment efficiency of 98.10±0.24% and DL of 69.32±0.44% with particle size and zeta potential
as 344±5 nm and −42±11.40 mV, respectively. DSC, FTIR, and XRD studies confirmed the drug entrapment within nanoparticle matrix. SEM results
showed spherical-shaped particles. Sustained release of drug from the nanoparticles was observed for 24 hrs period. Respirable fraction up to
52.37±0.7% demonstrates the formulation suitability for deep lung delivery. Lung inflammatory study showed a less inflammatory response.
Conclusion: Ionotropic gelation method can be used to prepare biocompatible particles with a high entrapment efficiency, DL, optimum particle size,
and controlled release characteristics, which can serve as a convenient delivery system for D-CS and could be a potential alternative to the existing
conventional therapy in MDR-TB.
Keywords: Nanoparticles, Alginate, Chitosan, Inhalation, Sustained release, Tuberculosis.
3
Downloads
References
REFERENCES
Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC.
Evolution of tuberculosis control and prospects for reducing
tuberculosis incidence, prevalence, and deaths globally. JAMA
;293(22):2767-75.
Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages
of nanoparticle drug delivery systems in chemotherapy of tuberculosis.
Am J Respir Crit Care Med 2005;172(12):1487-90.
Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant
tuberculosis in Europe: A systematic review. Thorax 2006;61(2):158-63.
Grosset JH, Singer TG, Bishai WR. New drugs for the treatment
of tuberculosis: Hope and reality. Int J Tuberc Lung Dis
;16(8):1005-14.
Li P, Dai YN, Zhang JP, Wang AQ, Wei Q. Chitosan-alginate
nanoparticles as a novel drug delivery system for nifedipine. Int J
Biomed Sci 2008;4(3):221-8.
Justo OR, Moraes AM. Kanamycin incorporation in lipid vesicles
prepared by ethanol injection designed for tuberculosis treatment.
J Pharm Pharmacol 2005;57(1):23-30.
Irache JM, Merodio M, Arnedo A, Camapanero MA, Mirshahi M,
Espuelas S. Albumin nanoparticles for the intravitreal delivery of
anticytomegaloviral drugs. Mini Rev Med Chem 2005;5(3):293-305.
Umamaheshwari RB, Ramteke S, Jain NK. Anti-Helicobacter
pylori effect of mucoadhesive nanoparticles bearing amoxicillin in
experimental gerbils model. AAPS PharmSciTech 2004;5(2):e32.
Pandey R, Ahmad Z, Sharma S, Khuller GK. Nano-encapsulation of
azole antifungals: Potential applications to improve oral drug delivery.
Int J Pharm 2005;301(1-2):268-76.
Lucinda-Silva RM, Evangelista RC. Microspheres of alginate-chitosan
containing isoniazid. J Microencapsul 2003;20(2):145-52.
Khuller GK, Kapur M, Sharma S. Liposome technology for
drug delivery against mycobacterial infections. Curr Pharm Des
;10(26):3263-74.
Qurrat-ul-Ain, Sharma S, Khuller GK, Garg SK. Alginate-based
oral drug delivery system for tuberculosis: Pharmacokinetics and
therapeutic effects. J Antimicrob Chemother 2003;51(4):931-8.
Pandey R, Khuller GK. Chemotherapeutic potential of alginate-chitosan
microspheres as anti-tubercular drug carriers. J Antimicrob Chemother
;53(4):635-40.
Xiong MH, Bao Y, Yang XZ, Zhu YH, Wang J. Delivery of antibiotics
with polymeric particles. Adv Drug Deliv Rev 2014;78:63-76.
Mi FL, Sung HW, Shyu SS. Drug release from chitosan- alginate
complex beads reinforced by a naturally occurring crosslinking agent.
Carbohydr Polym 2002;48(1):61-72.
Coppi G, Iannuccelli V, Leo E, Bernabei MT, Cameroni R. Protein
immobilization in crosslinked alginate microparticles. J Microencapsul
;19(1):37-44.
Kulkarni PV, Keshavayya J. Chitosan – Sodium alginate biodegradable
Interpenetrating Polymer Network (IPN) beads for delivery of ofloxacin
hydrochloride. Int J Pharm Pharm Sci 2010;2 Suppl 2:77-82.
Reddy BV, Kumar KH, Chandra SR, Chandra AS, Babu GD, Chandra P.
Preparation and in-vitro evaluation of ofloxacin mucoadhesive
microspheres. Int J Pharm Pharm Sci 2012;4(1):93-6.
Sathali AA, Varun J. Formulation, development and in vitro evaluation
of candesartan cilexetil mucoadhesive microbeads. Int J Curr Pharm
Res 2012;4(3):109-18.
V’Ooteghem MM. In: Edman P, editor. Biopharmaceutics of Ocular
Drug Delivery. Boca Raton: CRC Press; 1993. p. 27-41.
Rajaonarivony M, Vauthier C, Couarraze G, Puisieux F, Couvreur P.
Development of a new drug carrier made from alginate. J Pharm Sci
;82(9):912-7.
Arora S, Gupta S, Narang RK, Budhiraja RD. Amoxicillin
loaded chitosan-alginate polyelectrolyte complex nanoparticles
as mucopenetrating delivery system for H. Pylori. Sci Pharm
;79(3):673-94.
Motwani SK, Chopra S, Talegaonkar S, Kohli K, Ahmad FJ,
Khar RK. Chitosan-sodium alginate nanoparticles as submicroscopic
reservoirs for ocular delivery: Formulation, optimisation and in vitro
characterisation. Eur J Pharm Biopharm 2008;68(3):513-25.
Mali AJ, Pawar AP, Purohit RN. Development of budesonide loaded
biopolymer based dry powder inhaler: Optimization, in vitro deposition,
and cytotoxicity study. J Pharm (Cairo) 2014;2014:795371.
Jabłczyńska K, Janczewska M, Kulikowska A, Sosnowski T. Preparation
and characterization of biocompatible polymer particles as potential
nanocarriers for inhalation therapy. Int J Polym Sci 2015;2015:1-8.
Kondej D, Sosnowski TR. Changes in the activity of the pulmonary
surfactant after contact with bentonite nanoclay particles. Chem Eng
Trans 2012;26:531-6.
Mann JF, McKay PF, Arokiasamy S, Patel RK, Klein K, Shattock RJ.
Pulmonary delivery of DNA vaccine constructs using deacylated PEI
elicits immune responses and protects against viral challenge infection.
J Control Release 2013;170(3):452-9.
Sarmento B, Ferreira D, Veiga F, Ribeiro A. Characterization of insulinloaded
alginate nanoparticles produced by ionotropic pre-gelation
through
DSC and FTIR studies. Carbohydr Polym 2006;66(1):1-7.
Malesu VK, Sahoo D, Nayak PL. Chitosan-sodium alginate
nanocomposites blended with cloisite 30b as a novel drug delivery
system for anticancer drug curcumin. Int J Appl Biol Pharm Technol
;2(3):402-11.
Emami J, Boushehri MS, Varshosaz J. Preparation, characterization and
optimization of glipizide controlled release nanoparticles. Res Pharm
Sci 2014;9(5):301-14.
Desai TR, Hancock RE, Finlay WH. A facile method of delivery of
liposomes by nebulization. J Control Release 2002;84(1-2):69-78.
Matilainen L, Järvinen K, Toropainen T, Näsi E, Auriola S, Järvinen T,
et al. In vitro evaluation of the effect of cyclodextrin complexation
on pulmonary deposition of a peptide, cyclosporin A. Int J Pharm
;318(1-2):41-8.
Haberl N, Hirn S, Wenk A, Diendorf J, Epple M, Johnston BD,
et al. Cytotoxic and proinflammatory effects of PVP-coated silver
nanoparticles after intratracheal instillation in rats. Beilstein J
Nanotechnol 2013;4:933-40.
Neupane YR, Sabir MD, Ahmad N, Ali M, Kohli K. Lipid drug
conjugate nanoparticle as a novel lipid nanocarrier for the oral delivery
of decitabine: Ex vivo gut permeation studies. Nanotechnology
;24(41):415102.
Patel JK, Patel RP, Amin AF, Patel MM. Formulation and evaluation
of mucoadhesive glipizide microspheres. AAPS PharmSciTech
;6(1):E49-55.
Gazori T, Khoshayand MR, Azizi E, Yazdizadeh PN, Nomani A,
Haririan I. Evaluation of alginate/chitosan anoparticles as antisense
delivery vector: Formulation, optimization and in vitro characterization.
Carbohydr Polym 2009;77(3):599-606.
Sartori C, Finch D, Ralph B, Gilding K. Determination of the
cation content of alginate thin films by FTIR spectroscopy. Polymer
;38(1):43-51.
Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. Reversed
chitosan-alginate polyelectrolyte complex for stability improvement
of alpha-amylase: Optimization and physicochemical characterization.
Eur J Pharm Biopharm 2007;65(2):215-32.
Chen SC, Wu YC, Mi FL, Lin YH, Yu LC, Sung HW. A novel pH-
sensitive hydrogel composed of N,O-carboxymethyl chitosan and
alginate cross-linked by genipin for protein drug delivery. J Control
Release 2004;96(2):285-300.
Yoksan R, Jirawutthiwongchai J, Arpo K. Entrapment of ascorbyl
Asian J Pharm Clin Res, Vol 9, Suppl. 2, 2016, 82-95
Shaji and Shaikh
palmitate in chitosan nanoparticles by oil-in-water emulsion and ionic
gelation processes. Colloids Surf B Biointerfaces 2010;76(1):292-7.
Qi L, Xu Z, Jiang X, Hu C, Zou X. Preparation and antibacterial activity
of chitosan nanoparticles. Carbohydr Res 2004;339(16):2693-700.
Zhang LF, Yang DJ, Chen HC, Sun R, Xu L, Xiong ZC, et al. An
ionically crosslinked hydrogel containing vancomycin coating
on a porous scaffold for drug delivery and cell culture. Int J Pharm
;353(1-2):74-87.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
